Can ovarian cancer be cured in the middle stage?
Patients with mid-stage ovarian cancer may be better controlled through standardized treatment. The therapeutic effect of mid-term ovarian cancer is mainly related to the pathological type, degree of differentiation, treatment options and individual differences among patients. Early identification and comprehensive treatment are the keys to improving the prognosis.
Epithelial ovarian cancer is the most common type, accounting for approximately 90 percent of ovarian cancers. Such patients may have pelvic spread or peritoneal metastasis in the mid-term, and tumor resectability needs to be evaluated at this time. Staged surgery is the standard treatment, with the goal of removing as much visible disease as possible. Adjuvant chemotherapy is usually required after surgery, and common regimens include paclitaxel combined with carboplatin. In recent years, targeted drugs such as PARP inhibitors have also been used in patients with specific gene mutations, which can prolong progression-free survival. Radiation therapy has a limited role in advanced ovarian cancer but can be used to relieve certain symptoms. Some patients may achieve longer disease-free survival after initial treatment.
Certain histological types of ovarian cancer have a poor prognosis, such as small cell carcinoma or sarcomatoid carcinoma. These types have low sensitivity to chemotherapy and are prone to early recurrence. Borderline tumors are tumors of low malignant potential and are relatively indolent, even if metastatic. Germ cell tumors are sensitive to platinum-based chemotherapy, and fertility-sparing surgery may be appropriate in younger patients. Molecular testing can help guide precise treatment. For example, patients with BRCA mutations are more suitable for PARP inhibitor maintenance therapy. Immune checkpoint inhibitors show some promise in triple-negative ovarian cancer.
Follow-up after treatment for ovarian cancer is very important and requires regular review of tumor markers and imaging. Nutritional support can help reduce side effects of treatment, and a low-fat, high-protein diet is recommended. Moderate exercise can improve quality of life, but strenuous activities need to be avoided. Psychological counseling is particularly important for patients who have been living with cancer for a long time. Any new symptoms should be communicated with the attending doctor promptly and the treatment plan should be adjusted if necessary.
Disclaimer:
1. This article is sourced from the Internet. All content represents the author's personal views only and does not reflect the stance of this website. The author shall be solely responsible for the content.
2. Part of the content on this website is compiled from the Internet. This website shall not be liable for any civil disputes, administrative penalties, or other losses arising from improper reprinting or citation.
3. If there is any infringing content or inappropriate material, please contact us to remove it immediately. Contact us at:

